Certara, Inc. (CERT)
CERT Stock Price Chart
Explore Certara, Inc. interactive price chart. Choose custom timeframes to analyze CERT price movements and trends.
CERT Company Profile
Discover essential business fundamentals and corporate details for Certara, Inc. (CERT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
11 Dec 2020
Employees
1.49k
Website
https://www.certara.comCEO
Jon Resnick
Description
Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes with its innovative biosimulation software and expertise. Its extensive portfolio of technology-enabled services includes mechanistic and empirical biosimulation, strategic guidance for drug development and regulatory affairs, clinical pharmacology, model-based meta-analysis, specialized regulatory writing and medical communications, regulatory operations support, and market access consultation. Furthermore, Certara offers a robust suite of software platforms covering mechanistic and empirical PK/PD biosimulation, data standardization and compliance, scientific informatics, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions, and market access communication. The company's clientele primarily comprises biopharmaceutical firms, academic institutions, and governmental organizations. Established in 2008 and headquartered in Princeton, New Jersey, Certara maintains a significant global presence, with operations spanning numerous countries including the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China.
CERT Financial Timeline
Browse a chronological timeline of Certara, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is $0.10, while revenue estimate is $98.09m.
Earnings released on 11 May 2026
EPS came in at $0.09 falling short of the estimated $0.11 by -18.18%, while revenue for the quarter reached $106.92m , beating expectations by +0.74%.
Earnings released on 26 Feb 2026
EPS came in at $0.09 falling short of the estimated $0.11 by -18.18%, while revenue for the quarter reached $103.60m , beating expectations by +0.51%.
Earnings released on 6 Nov 2025
EPS came in at $0.14 surpassing the estimated $0.11 by +27.27%, while revenue for the quarter reached $104.62m , beating expectations by +1.34%.
Earnings released on 6 Aug 2025
EPS came in at $0.07 falling short of the estimated $0.10 by -30.00%, while revenue for the quarter reached $104.57m , beating expectations by +0.47%.
Earnings released on 5 May 2025
EPS came in at $0.14 surpassing the estimated $0.13 by +7.69%, while revenue for the quarter reached $106.00m , beating expectations by +1.66%.
Earnings released on 26 Feb 2025
EPS came in at $0.15 surpassing the estimated $0.13 by +15.38%, while revenue for the quarter reached $100.36m , beating expectations by +1.24%.
Earnings released on 6 Nov 2024
EPS came in at $0.13 surpassing the estimated $0.11 by +18.18%, while revenue for the quarter reached $94.82m , missing expectations by -3.50%.
Earnings released on 6 Aug 2024
EPS came in at $0.07 falling short of the estimated $0.11 by -36.36%, while revenue for the quarter reached $93.31m , missing expectations by -2.85%.
Earnings released on 7 May 2024
EPS came in at $0.10 matching the estimated $0.10, while revenue for the quarter reached $96.65m , beating expectations by +3.22%.
Earnings released on 29 Feb 2024
EPS came in at $0.09 falling short of the estimated $0.11 by -18.18%, while revenue for the quarter reached $88.01m , beating expectations by +1.63%.
Earnings released on 8 Nov 2023
EPS came in at $0.11 matching the estimated $0.11, while revenue for the quarter reached $85.58m , missing expectations by -1.18%.
Earnings released on 9 Aug 2023
EPS came in at $0.12 falling short of the estimated $0.13 by -7.69%, while revenue for the quarter reached $90.45m , missing expectations by -1.88%.
Earnings released on 8 May 2023
EPS came in at $0.12 matching the estimated $0.12, while revenue for the quarter reached $90.30m , missing expectations by -0.76%.
Earnings released on 1 Mar 2023
EPS came in at $0.16 surpassing the estimated $0.14 by +14.29%, while revenue for the quarter reached $86.63m , beating expectations by +4.95%.
Earnings released on 7 Nov 2022
EPS came in at $0.10 falling short of the estimated $0.11 by -9.09%, while revenue for the quarter reached $84.70m , beating expectations by +3.69%.
Earnings released on 9 Aug 2022
EPS came in at $0.09 falling short of the estimated $0.11 by -18.18%, while revenue for the quarter reached $82.76m , missing expectations by -3.16%.
Earnings released on 5 May 2022
EPS came in at $0.11 matching the estimated $0.11, while revenue for the quarter reached $81.55m , beating expectations by +2.09%.
Earnings released on 1 Mar 2022
EPS came in at $0.01 falling short of the estimated $0.09 by -88.89%, while revenue for the quarter reached $75.35m , missing expectations by -9.50%.
Earnings released on 9 Nov 2021
EPS came in at $0.07 surpassing the estimated $0.06 by +16.67%, while revenue for the quarter reached $73.94m , beating expectations by +2.36%.
Earnings released on 5 Aug 2021
EPS came in at $0.03 falling short of the estimated $0.05 by -40.00%, while revenue for the quarter reached $70.10m , beating expectations by +0.96%.
CERT Stock Performance
Access detailed CERT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
